For laboratory research use only — not for human or veterinary consumption.
The Peptide Index
Dosing guide

KPV Dosage Chart & Schedule

A tripeptide fragment (Lys-Pro-Val) derived from the C-terminus of alpha-MSH, studied for anti-inflammatory effects, particularly in models of gut inflammation.

Route
Subcutaneous
Frequency
Once daily
Half-life
Short, as expected for a tripeptide
Storage
Refrigerate reconstituted; protect from light.
The short answer

KPV is a tripeptide fragment of alpha-MSH studied for anti-inflammatory effects, particularly in gut-inflammation models. There is no established human dosing; research-community sources reference roughly 200-500 mcg, used subcutaneously or orally.

Figures describe how KPV is reported in the research literature and research-community references — not a recommendation for human use. For laboratory research only.

Dosage protocols

Commonly referenced research tiers. Start conservative; every compound and study context differs.

Starter
200 mcg
Low end of the research-community range.
Frequency
Once daily
Weekly total
~1.4 mg/week
Cycle
Short research courses

Anti-inflammatory effects are reported mainly in cell and rodent gut models.

Most commonStandard
500 mcg
Upper end of the commonly referenced range.
Frequency
Once daily
Weekly total
~3.5 mg/week
Cycle
Short research courses

Referenced for gut-focused work; no validated human dosing exists.

Gut-inflammation focus

  • Studied for dampening pro-inflammatory signaling (notably NF-kB) without the pigmentation effects of full alpha-MSH.
  • Anti-inflammatory effects are reported mainly in cell and rodent gut-inflammation models.

Ready to run this protocol?

Dosing is only as good as the vial. KPV is third-party tested with published COAs from our top-rated source — reconstitute with confidence and skip the guesswork on identity and purity.

Weekly schedule

A typical week on the standard protocol (Once daily).

Mon
Tue
Wed
Thu
Fri
Sat
Sun

Dosing day Off

From vial to injection in 6 steps

1

Wipe both vial tops

Swab the peptide vial and the bacteriostatic-water vial with fresh alcohol and let them dry.

2

Draw the water

Pull the planned amount of bacteriostatic water (2 mL) into the syringe.

3

Add it slowly

Run the water down the inside wall of the vial — don't blast the powder. Swirl gently; never shake.

4

Let it dissolve

Wait until the solution is fully clear, then refrigerate the vial.

5

Draw your dose

Pull the calculated units on a U-100 insulin syringe.

6

Store between uses

Keep the reconstituted vial refrigerated and use within its stable window.

Handling & storage

  • Reconstitute with bacteriostatic water (a 10 mg vial in about 2 mL gives 5,000 mcg/mL); per-dose volumes are small (a 500 mcg dose is about 0.1 mL).
  • Research use is subcutaneous or oral; gut-focused work sometimes favors oral administration.
  • Refrigerate the reconstituted solution and protect it from light.

KPV dosing FAQ

How is KPV used in research?

It is referenced both subcutaneously and orally, with oral use featuring in gut-inflammation work.

What amount is typically referenced?

Research-community sources cite roughly 200-500 mcg, though there is no validated human dose.

Is there an established human dose?

No. Anti-inflammatory effects are reported in cell and rodent gut models, so the figures are research references only.

Sources

Categories: Immune & Gut, Healing & Recovery · Status: Research use only. This page is educational and for laboratory research use only; it is not medical advice.